Beam Therapeutics(BEAM) - 2023 Q3 - Quarterly Report

Beam Therapeutics Inc. (Exact name of Registrant as specified in its Charter) ☐ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | --- | --- | --- | |-----------------------------------------|-------------------|-----------------------------------------------------| | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | Common Stock, par value $0.01 per share | BEAM | Nasdaq Global Select Market | This Quarterly Report on Form 10-Q ...